UK Parkinson's Disease Consortium (UKPDC) United Kingdom (UK)
Research
Date range: 1 January 2023 - 31 December 2023
Research collaboration: UK Parkinson's Disease Consortium (UKPDC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Partner Institutions
UK Parkinson's Disease Consortium (UKPDC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Academic Medical Center (AMC), UvA
- Brain and Spine Institute (ICM)
- Cambridge Bristol Toronto Hamburg Neurodegenerative Disease Consortium
- Cardiff University
- Eisai Co., Ltd.
- Hertie Institute for Clinical Brain Research (HIH), Uni Tübingen
- King's College London (KCL)
- MRC Centre for Neuromuscular Diseases (London)
- MRC Centre for Regenerative Medicine (CRM), The University of Edinburgh
- MRC Protein Phosphorylation and Ubiquitylation Unit (PPU), University of Dundee
- MRC Toxicology Unit, University of Cambridge
- NIH National Institute on Aging (NIA)
- National Hospital for Neurology and Neurosurgery (NHNN), UCLH
- National Institute for Health and Medical Research (INSERM)
- Neurodegenerative Diseases Initiative (NDI)
- Physiopathology Center of Toulouse-Purpan (CPTP)
- Royal Free Hospital
- The Institute of Cancer Research (ICR)
- The University of Edinburgh
- The University of Sheffield
- UCL
- University of Aberdeen
- University of Birmingham (UB)
- University of Cambridge
- VU University Medical Center (VUmc)
- Wellcome Sanger Institute
- Wellcome Trust Case Control Consortium (WTCCC)